These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32133702)

  • 1. A-kinase interacting protein 1 (AKIP1) associates with advanced overall disease condition, tumor properties, and unfavorable prognosis in hepatocellular carcinoma patients.
    Fang T; Lu Q
    J Clin Lab Anal; 2020 Jun; 34(6):e23213. PubMed ID: 32133702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-kinase interacting protein 1 as a potential biomarker of advanced tumor features and increased recurrence risk in papillary thyroid carcinoma patients.
    Zhang L; Tao H; Ke K; Ma C
    J Clin Lab Anal; 2020 Oct; 34(10):e23452. PubMed ID: 32643206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
    Shen S; Yao Y
    Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
    Liu Y; Tian J; Qin D; Liu J; Xie Y
    J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer.
    Wang D; Luo Y; Guo Y; Li G; Li F
    Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher tumor protein kinase D1 correlates with increased tumor size, BCLC stage, CA199 level, AFP level and worse overall survival in hepatocellular carcinoma patients.
    Ge J; Zhang X; Zhang B; Zhu L; Zhao M; Gao W; Chen D
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101573. PubMed ID: 33281070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of a kinase interacting protein 1 in tongue squamous cell carcinoma correlates with lymph node metastasis and poor overall survival.
    Sun Y; Shi G; Ma C; Jiao J; Liu Y; Gao Q; Zhang X; Feng Q
    Medicine (Baltimore); 2021 Apr; 100(14):e25278. PubMed ID: 33832094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
    Yan Y; Li X; Gao J
    J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A-kinase interacting protein 1 high expression correlates with advanced tumor stage and poor overall survival in surgical patients with clear cell renal cell carcinoma.
    Peng H; Zhang R; Zhang H
    Medicine (Baltimore); 2020 Jun; 99(24):e20742. PubMed ID: 32541526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated circ_0004913, circ_0008160, circ_0000517, and their potential as biomarkers for disease monitoring and prognosis in hepatocellular carcinoma.
    Li X; Yang J; Yang X; Cao T
    J Clin Lab Anal; 2021 Jun; 35(6):e23785. PubMed ID: 34018640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile.
    Wu D; Zhang R; Zhan L
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101812. PubMed ID: 34597849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
    Cheng F; Wang L; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23300. PubMed ID: 32319701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients.
    Lin R; Zhao S; Su L; Chen X; Xu C; He Q; Zhuo C; Ye Y
    J Clin Lab Anal; 2020 Aug; 34(8):e23350. PubMed ID: 32672362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Wang X; Wang Z; Wu L
    BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical value of kinesin superfamily protein 2A in hepatocellular carcinoma.
    Liu W; Xu C; Meng Q; Kang P
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101527. PubMed ID: 33713978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.